CRP is also a strong prognostic predictor in many cancers, including metastatic renal cell carcinoma, advanced pancreatic cancer, gastric cancer, breast cancer, colorectal cancer, inoperative non-small cell lung cancer, prostate cancer, pancreatic cancer, and esophageal cancer [16,17]. This evidence concerns the gene CRP and pancreatic neoplasm.